AH
Andrew Hahn
Research areas: Medicine · Oncology · Prostate Cancer Treatment and Research · Prostate Cancer Diagnosis and Treatment · Cancer Immunotherapy and Biomarkers
0000-0002-4153-205X
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (125)
- A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo) Save
- Data from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Figure S1 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Figure S2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Figure S3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Figure S4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Figure S5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Figure S6 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Figure S7 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Figure S8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Table 2 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Table 3 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Table 4 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Table 5 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Supplementary Tables 1 and 6-8 from Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma Save
- Body composition as a determinant of the therapeutic index with androgen signaling inhibition Save
- MDT perspective: innovative applications of stereotactic body radiation therapy in metastatic castration-resistant prostate cancer Save
- Stratifying and Treating Metastatic Castration-Sensitive Prostate Cancer Using PSMA PET Results: Insights from the RADAR VIII Meeting Save
- The need for precision medicine in managing cardiovascular risk for men receiving ADT Save
- A phase II trial of sitravatinib + nivolumab after progression on immune checkpoint inhibitor in patients with metastatic clear cell RCC Save